NAD+ Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice Regenerative Medicine 25/05/2020
NAD+ Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases Regenerative Medicine 25/04/2020
NAD+ Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular Ageing Regenerative Medicine 25/03/2020
NAD+ Enhancing NAD+ salvage metabolism is neuroprotective in a PINK1 model of Parkinson’s disease Regenerative Medicine 25/01/2020
Regenerative Medicine Co., Ltd. Proudly Announces Exclusive Partnership for InfiNADi NAD+ Products in Vietnam Regenerative Medicine June 27, 2024
NAD+ Repletion Rescues Female Fertility during Reproductive Aging Regenerative Medicine August 25, 2020
Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19 Regenerative Medicine August 20, 2020
NAD+ Repletion Rescues Female Fertility during Reproductive Aging Regenerative Medicine August 25, 2020
The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson’s Disease Regenerative Medicine June 7, 2020
